Related Experiment Video
Updated: Feb 23, 2026

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells
Published on: July 6, 2021
Remodeling KRAS
Daniel J Deredge1, Patrick L Wintrode1
1Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 North Pine St., Baltimore, MD 21201, USA.
Abstract:
Mutations in members of the RAS family of small GTPases have been associated with numerous human cancers. However, RAS family members are notoriously difficult to target. In this issue of Structure, Lu et al. (2017) examine the effects of two compounds with distinct chemical scaffolds on the structure and dynamics of an oncogenic KRAS mutant, thus highlighting the usefulness of HDX-MS for drug development.
Insights
Targeting cancer-driving RAS proteins is challenging. This study uses hydrogen-deuterium exchange mass spectrometry (HDX-MS) to analyze compounds affecting an oncogenic KRAS mutant, aiding drug development.
Area of Science:
- Oncogenic signaling pathways
- Protein structure and dynamics
- Drug discovery and development
Background:
- Mutations in RAS family small GTPases are implicated in various human cancers.
- RAS proteins are historically difficult to target therapeutically due to their structure and function.
- Oncogenic KRAS mutations drive tumor growth and represent a significant unmet medical need.
Purpose of the Study:
- To investigate the structural and dynamic effects of two distinct chemical compounds on an oncogenic KRAS mutant.
- To evaluate the utility of Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) as a tool for characterizing drug interactions with RAS proteins.
- To provide insights into potential strategies for targeting KRAS-driven cancers.
Main Methods:
- Utilized Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) to monitor protein structural dynamics.
- Analyzed the interaction of two small molecules with different chemical scaffolds against a specific oncogenic KRAS mutant.
- Characterized changes in protein structure and dynamics upon compound binding.
Main Results:
- Observed distinct effects of the two compounds on the structure and dynamics of the oncogenic KRAS mutant.
- HDX-MS successfully captured compound-induced conformational changes in KRAS.
- The study identified specific regions of KRAS affected by the tested compounds.
Conclusions:
- HDX-MS is a valuable technique for studying the effects of small molecules on RAS protein structure and dynamics.
- Understanding these interactions is crucial for developing effective therapies against KRAS-mutated cancers.
- The findings support the continued development of novel KRAS-targeting drugs.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Renewal of Skin Epidermal Stem Cells
Homologous Recombination

